NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

  • February 2021 •
  • 166 pages •
  • Report ID: 5882047 •
  • Format: PDF
KEY FINDINGS
The North America pharmaceutical continuous manufacturing market is set to record a CAGR of 9.95% during the forecast period, 2021-2028. The increasing adoption of advanced technologies, the large presence of pharmaceutical & biopharmaceutical companies, and the higher adoption of advanced technologies, drive market growth.

MARKET INSIGHTS
The North America pharmaceutical continuous manufacturing market growth analysis entails the assessment of Canada and the United States.The Canadian pharmaceutical industry is transitioning to respond to new realities.

These include the unprecedented expiration of patents for several blockbuster drugs and the cost containment measures from both private and public payers.Such external forces, coupled with the competitive global corporate dynamic for investment and enhanced returns, will aid in reshaping their operations.

The changes at the global level have a deep impact on the Canadian pharmaceutical industry, leading to new opportunities and threats.According to the government, the pharmaceutical industry entails an ecosystem of local and multinational companies.

Further, the Canadian Generic Pharmaceutical Association (CGPA) has ten member companies. Of these, more than half are under non-Canadian corporations. Moreover, branded pharmaceutical MNEs represent the largest portion of the drug sales and R&D investment. Such aspects contribute to the overall growth of the market.

COMPETITIVE INSIGHTS
Some of the major players in the market include Hosokawa Micron Corporation, Eli Lilly & Company, Glatt GmbH, Gebruder Lodige Maschinenbau GmbH, Korsch AG, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. COPERION GMBH
2. ELI LILLY & COMPANY
3. GEA GROUP AG
4. GEBRUDER LODIGE MASCHINENBAU GMBH
5. GLATT GMBH
6. HOSOKAWA MICRON CORPORATION
7. KORSCH AG
8. LB BOHLE MASCHINEN + VERFAHREN GMBH
9. MUNSON MACHINERY COMPANY
10. PFIZER INC
11. SIEMENS HEALTHINEERS
12. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
13. THERMO FISHER SCIENTIFIC INC